Study of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Lymphoma

Clinical trial NCT05757700 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05757700
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-Cell Lymphoma Large B-cell Lymphoma DLBCL, Nos Genetic Subtypes High-grade B Cell Lymphoma Mediastinal Large B-cell Lymphoma

Start date: 2023-02-23
Primary completion: 2027-02-23
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.